A TOXICITY STUDY OF RECOMBINANT INTERFERON-GAMMA GIVEN BY INTRAVENOUS-INFUSION TO PATIENTS WITH ADVANCED CANCER

被引：35

作者：

SRISKANDAN, K

GARNER, P

WATKINSON, J

PETTINGALE, KW

BRINKLEY, D

CALMAN, FMB

TEE, DEH

机构：

[1] UNIV LONDON KINGS COLL HOSP, SCH MED, DEPT IMMUNOL, DENMARK HILL, LONDON SE5 9RS, ENGLAND

[2] UNIV LONDON KINGS COLL HOSP, SCH MED, DEPT MED, LONDON SE5 9RS, ENGLAND

[3] UNIV LONDON KINGS COLL HOSP, SCH MED, DEPT RADIOTHERAPY, LONDON SE5 9RS, ENGLAND

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1986年 / 18卷 / 01期

关键词：

D O I：

10.1007/BF00253067

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：63 / 68

页数：6

共 31 条

[1]

Armstrong J A, 1981, Methods Enzymol, V78, P381

[2] PURIFIED HUMAN IMMUNE INTERFERON HAS MORE POTENT ANTICELLULAR ACTIVITY THAN FIBROBLAST OR LEUKOCYTE INTERFERON [J].

BLALOCK, JE ;

GEORGIADES, JA ;

LANGFORD, MP ;

JOHNSON, HM .

CELLULAR IMMUNOLOGY, 1980, 49 (02) :390-394

[3]

BORDEN EC, 1984, CANCER, V53, P783, DOI 10.1002/1097-0142(19840201)53:3+<783::AID-CNCR2820531329>3.0.CO

[4]

2-I

[5] INTERFERONS - RATIONALE FOR CLINICAL-TRIALS IN NEOPLASTIC DISEASE [J].

BORDEN, EC .

ANNALS OF INTERNAL MEDICINE, 1979, 91 (03) :472-479

[6]

BORGSTROM S, 1982, NEW ENGL J MED, V307, P1080

[7] CIRCULATING INTERFERON IN RABBITS AND MONKEYS AFTER ADMINISTRATION OF HUMAN GAMMA-INTERFERON BY DIFFERENT ROUTES [J].

CANTELL, K ;

HIRVONEN, S ;

PYHALA, L ;

DEREUS, A ;

SCHELLEKENS, H .

JOURNAL OF GENERAL VIROLOGY, 1983, 64 (AUG) :1823-1826

[8]

DECLERCQ E, 1982, J NATL CANCER I, V69, P653

[9] THE TREATMENT OF RENAL-CELL CARCINOMA WITH HUMAN-LEUKOCYTE ALPHA-INTERFERON [J].

DEKERNION, JB ;

SARNA, G ;

FIGLIN, R ;

LINDNER, A ;

SMITH, RB .

JOURNAL OF UROLOGY, 1983, 130 (06) :1063-1066

[10]

FLEISCHMANN WR, 1982, CANCER RES, V42, P869

← 1 2 3 4 →